CCG-232964
Product Specifications
UNSPSC Description
CCG-232964 is an orally active inhibitor of Rho/MRTF/SRF. CCG-232964 inhibits LPA-induced CTGF gene expression[1].
Target Antigen
Ras; ROCK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage;Cytoskeleton;GPCR/G Protein;MAPK/ERK Pathway;Stem Cell/Wnt;TGF-beta/Smad
Applications
Cancer-Kinase/protease
Field of Research
Cancer; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/ccg-232964.html
Solubility
10 mM in DMSO
Smiles
O=C(O)CCCSC1=NN=C(C2=CC=C(C3CC3)C=C2Cl)O1
Molecular Weight
338.81
References & Citations
[1]Kahl, Dylan, et al. 5-Aryl-1,3,4-oxadiazol-2-ylthioalkanoic Acids: A Highly Potent New Class of Inhibitors of Rho/Myocardin-Related Transcription Factor (MRTF)/Serum Reponse Factor (SRF)-Mediated Gene Transcription as Potential Antifibrotic Agents for Scleroderma. Journal of Medicinal Chemistry, (), acs.jmedchem.8b01772–.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-130011/CCG-232964-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-130011/
Clinical Information
No Development Reported
CAS Number
2349373-70-0
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rabbit Polyclonal RelA/NFkB p65 [p Ser276] Antibody](https://cdn.genprice.uk/genprice/genprice5.png)
